The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

AEterna Zentaris Inc

Nasdaq: AEZS
Last

(U.S.) $3.20

Today's change+0.19 +6.31%
Updated June 28 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

AEterna Zentaris Inc

Nasdaq: AEZS
Last

(U.S.) $3.20

Today's change+0.19 +6.31%
Updated June 28 4:00 PM -4GMT. Delayed by at least 15 minutes.

AEterna Zentaris Inc up sharply

AEterna Zentaris Inc closed up sharply Tuesday, rallying (U.S.)$0.19 or 6.31% to (U.S.)$3.20. Over the last five days, shares have lost 9.86% and are down 28.57% for the last year to date. This security has underperformed the S&P 500 by 85.46% during the last year.

Key company metrics

  • Open(U.S.) $3.12
  • Previous close(U.S.) $3.01
  • High(U.S.) $3.22
  • Low(U.S.) $3.00
  • Bid / Ask(U.S.) $1.00 / (U.S.) $3.31
  • YTD % change-28.57%
  • Volume121,289
  • Average volume (10-day)136,698
  • Average volume (1-month)125,115
  • Average volume (3-month)242,546
  • 52-week range(U.S.) $2.60 to (U.S.) $28.60
  • Beta1.72
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$22.23
Updated June 28 4:00 PM -4GMT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-6,200.00%

AEterna Zentaris Inc has a net profit margin of -6,200.00%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX1.12%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue0000
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense71088
Selling / general / administrative4644
Research & development4444
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-7-10-8-8
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-4-10-15-15
Income after tax-4-10-15-15
Income tax, total--------
Net income-4-10-15-15
Total adjustments to net income--------
Net income before extra. items-4-10-15-15
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-4-10-15-15
Inc. avail. to common incl. extra. items-4-10-15-15
Diluted net income-4-10-15-15
Dilution adjustment--------
Diluted weighted average shares10721
Diluted EPS excluding extraordinary itemsvalue per share-0.37-1.45-6.71-13.69
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.37-1.45-6.71-13.69